Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Does amiodarone have a benefit effect on mortality?].

M Pathé1, J C Kahn

  • 1Service de Cardiologie, Hôpital Intercommunal, Poissy.

Presse Medicale (Paris, France : 1983)
|September 14, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infectious events during the course of autoimmune diseases treated with rituximab: A retrospective study of 93 cases].

La Revue de medecine interne·2016
Same author

A study of women who stalk.

The American journal of psychiatry·2001
Same author

[Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study].

Archives des maladies du coeur et des vaisseaux·2001
Same author

Stalking: new constructions of human behaviour.

The Australian and New Zealand journal of psychiatry·2001
Same author

Study of stalkers.

The American journal of psychiatry·1999
Same author

[Obstructive calcification of the aorta].

Presse medicale (Paris, France : 1983)·1999
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Amiodarone effectively treats severe ventricular arrhythmias and heart conditions, showing promise in reducing sudden cardiac death. Ongoing trials will clarify its long-term benefits and risks.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Amiodarone is an anti-arrhythmic and anti-ischaemic drug.
  • Its efficacy in severe ventricular arrhythmias and various heart diseases is noted.
  • Previous studies on its impact on sudden death had methodological limitations.

Purpose:

  • To evaluate amiodarone's effectiveness and safety in treating cardiac arrhythmias and related conditions.
  • To assess its potential to reduce sudden cardiac death.
  • To determine the benefit/risk ratio of long-term amiodarone treatment.

Summary:

  • Amiodarone demonstrates effectiveness in treating severe ventricular arrhythmias in conditions like dilated cardiomyopathies and hypertrophic or ischaemic heart diseases.
  • Unlike other antiarrhythmics, it appears to lack significant proarrhythmic or cardiac depressant effects.

Related Experiment Videos

  • Its anti-ischaemic properties are evident in managing angina.
  • Extracardiac side effects, such as thyroid and pulmonary issues, require careful monitoring but can often be managed or prevented.

    • Impact:

    • Amiodarone is a promising treatment for patients at high risk of sudden death, particularly those with ventricular arrhythmias.
    • Extensive clinical trials are underway to precisely ascertain its effect on mortality in post-myocardial infarction and heart failure patients.
    • These trials aim to establish a clearer benefit/risk profile for long-term amiodarone use.